HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: FDA campus plan

This article was originally published in The Rose Sheet

Executive Summary

FDA campus plan: FDA receives support for its campus plan at Clarksburg Triangle in Montgomery County from most of the surrounding community, according to comments made at a Feb. 2 public hearing. Offices for the Center for Food Safety and Applied Nutrition will be in Prince George's County; the site has not yet been determined. Consolidation of the agency's facilities could be threatened by the Republicans' mandate to downsize the federal government. Rep. John Duncan (R-TN), in Jan. 31 remarks in the House, urged the Administration to scrap the agency's campus plans in Montgomery and Prince Georges Counties. "At a time when we are supposed to be downsizing the federal government, the FDA wants to build a Taj Mahal complex of buildings in Maryland for a new headquarters," Duncan stated...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001283

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel